GLP-1 Medications for Weight Loss

Complete Guide 2025

Written by Kai Nakano, Health Journalist & Men's Health Specialist
Updated January 15, 2025
Medically reviewed by Dr. Amara Okonkwo, PharmD, BCPS - Clinical Pharmacotherapy Specialist

Quick Summary

GLP-1 medications (semaglutide, tirzepatide) cause 15-20% body weight loss by mimicking natural fullness hormones, reducing appetite and slowing digestion. FDA-approved for BMI 30+ or BMI 27+ with conditions. Semaglutide (Wegovy/Ozempic) costs $99-350/month; tirzepatide (Mounjaro/Zepbound) costs $350-550/month for brand-name, $99-299/month for compounded versions through online clinics. Weekly injections required indefinitely—weight regains within 6-12 months if stopped.

  • Average weight loss: semaglutide 15-17% of body weight, tirzepatide 20-22%; results appear in 4-8 weeks with peak at 12-18 months
  • Common side effects: nausea (40-50%), vomiting (10-20%), diarrhea (20-30%)—usually mild and subside after 4-8 weeks
  • Qualification: BMI 30+ or BMI 27+ with obesity-related conditions (diabetes, high blood pressure, sleep apnea); requires prescription
  • Must continue indefinitely for results—studies show 70% of weight regained within 12 months of stopping medication

What Are GLP-1 Medications?

GLP-1 (glucagon-like peptide-1) medications are a class of injectable drugs originally developed for type 2 diabetes that have proven remarkably effective for weight loss. These medications mimic a natural hormone your body produces after eating, leading to reduced appetite, increased feelings of fullness, and significant weight loss.

Popular GLP-1 medications:

  • Semaglutide: Ozempic (diabetes), Wegovy (weight loss)
  • Tirzepatide: Mounjaro (diabetes), Zepbound (weight loss)
  • Liraglutide: Victoza (diabetes), Saxenda (weight loss)

Key facts:

  • Average weight loss: 15-20% of body weight
  • FDA-approved for weight management
  • Weekly injections (most)
  • Require ongoing use to maintain results
  • Prescription only

How GLP-1 Medications Work

The Science Behind GLP-1

GLP-1 is a natural hormone your intestines produce after eating. It:

  1. Signals your brain that you’re full
  2. Slows stomach emptying (keeps you satisfied longer)
  3. Reduces appetite and cravings
  4. Helps regulate blood sugar

GLP-1 medications are synthetic versions that last much longer than natural GLP-1 (days vs. minutes), providing sustained appetite suppression and weight loss effects.

Effects on Your Body

Appetite and Satiety:

  • Dramatically reduces hunger
  • Creates strong feeling of fullness with less food
  • Reduces food cravings (especially for high-calorie foods)
  • Some describe it as “food noise” going quiet

Stomach and Digestion:

  • Slows gastric emptying (food stays in stomach longer)
  • Increases satisfaction from smaller portions
  • May cause nausea initially (usually improves)

Blood Sugar:

  • Improves insulin sensitivity
  • Lowers blood sugar (beneficial for pre-diabetes/diabetes)
  • Reduces HbA1c

Weight Loss:

  • Average 15-20% total body weight loss
  • More effective than lifestyle changes alone
  • Most weight loss occurs in first 6-12 months

Semaglutide (Ozempic/Wegovy)

Ozempic:

  • FDA-approved for type 2 diabetes
  • Widely prescribed off-label for weight loss
  • Doses: 0.25mg, 0.5mg, 1mg, 2mg weekly

Wegovy:

  • FDA-approved specifically for weight loss
  • Same medication as Ozempic, higher doses
  • Doses: 0.25mg up to 2.4mg weekly

Clinical Results:

  • Average weight loss: 15% of body weight (33 lbs if starting at 220 lbs)
  • 68-week study: Lost 15.3 kg (33.7 lbs) vs. 2.6 kg (5.7 lbs) placebo
  • ~70% of people lose 10%+ of body weight

Administration:

  • Once-weekly subcutaneous injection
  • Inject in abdomen, thigh, or upper arm

Cost:

  • Ozempic: $900-1,000/month without insurance
  • Wegovy: $1,300-1,500/month without insurance
  • Compounded semaglutide: $200-400/month through telehealth

Tirzepatide (Mounjaro/Zepbound)

Mounjaro:

  • FDA-approved for type 2 diabetes
  • Often prescribed off-label for weight loss
  • Doses: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg weekly

Zepbound:

  • FDA-approved for weight loss (newer)
  • Same medication as Mounjaro
  • Doses: 2.5mg up to 15mg weekly

Clinical Results:

  • Average weight loss: 20% of body weight (44 lbs if starting at 220 lbs)
  • 72-week study: Lost 20.9 kg (46 lbs) at highest dose
  • More effective than semaglutide in head-to-head trials

How it’s different:

  • Dual agonist: Activates both GLP-1 and GIP receptors
  • Generally more weight loss than semaglutide
  • Potentially fewer GI side effects

Cost:

  • Mounjaro: $1,000-1,100/month without insurance
  • Zepbound: $1,000-1,200/month without insurance
  • Compounded tirzepatide: $400-600/month through telehealth

Liraglutide (Saxenda)

Older GLP-1 medication:

  • Daily injection (not weekly)
  • Effective but less convenient
  • Average weight loss: 8-9% body weight
  • Less popular since semaglutide/tirzepatide available

Comparison Table

MedicationAvg Weight LossInjection FrequencyCost/MonthNotes
Semaglutide (Wegovy)15% body weightWeekly$1,300Most studied, effective
Tirzepatide (Zepbound)20% body weightWeekly$1,200Most effective, dual agonist
Liraglutide (Saxenda)8-9% body weightDaily$1,400Older, less convenient
Compounded versionsSimilarWeekly$200-600Affordable option

Who Should Use GLP-1 Medications?

FDA-Approved Criteria

GLP-1s approved for weight loss if you have:

  • BMI ≥30 (obese), OR
  • BMI ≥27 (overweight) with weight-related health condition:
    • Type 2 diabetes or pre-diabetes
    • High blood pressure
    • High cholesterol
    • Cardiovascular disease
    • Sleep apnea

Best candidates:

  • Have tried diet and exercise without success
  • Willing to commit to long-term treatment
  • Can afford cost (or have insurance coverage)
  • Don’t have contraindications

Who Should NOT Use GLP-1s

Contraindications:

  • Personal or family history of medullary thyroid cancer
  • Multiple endocrine neoplasia syndrome type 2 (MEN 2)
  • Pregnant or trying to become pregnant
  • Breastfeeding
  • History of pancreatitis
  • Severe gastrointestinal disease
  • History of diabetic retinopathy (with caution)

Use caution if:

  • History of eating disorders
  • Severe depression or suicidal ideation
  • Taking other weight loss medications

Starting GLP-1 Medication: What to Expect

Dose Titration Schedule

Semaglutide (Wegovy) typical schedule:

  • Month 1: 0.25mg weekly
  • Month 2: 0.5mg weekly
  • Month 3: 1.0mg weekly
  • Month 4: 1.7mg weekly
  • Month 5+: 2.4mg weekly (maintenance)

Tirzepatide (Zepbound) typical schedule:

  • Month 1: 2.5mg weekly
  • Month 2: 5.0mg weekly
  • Month 3: 7.5mg weekly
  • Month 4: 10mg weekly
  • Month 5+: 10-15mg weekly (maintenance)

Why slow titration?

  • Reduces side effects (especially nausea)
  • Allows body to adjust
  • Improves tolerability

Timeline for Results

Week 1-4:

  • Reduced appetite noticed immediately
  • Less hunger between meals
  • May lose 2-5 lbs
  • Some nausea possible

Month 2-3:

  • Weight loss accelerates
  • 1-2 lbs per week typical
  • Appetite suppression strong
  • Side effects usually improving

Month 4-6:

  • Steady weight loss continues
  • May lose 10-15% of starting weight
  • People start noticing your weight loss
  • Energy may improve

Month 6-12:

  • Maximum weight loss typically reached
  • ~15-20% total body weight lost
  • Weight stabilizes
  • Continue medication to maintain

Administration Tips

Injection technique:

  • Subcutaneous (under skin, not into muscle)
  • Rotate injection sites (abdomen, thigh, upper arm)
  • Use new needle each time
  • Inject same day each week

Reducing side effects:

  • Take with food in stomach (can reduce nausea)
  • Stay well-hydrated
  • Eat smaller, more frequent meals
  • Avoid high-fat, greasy foods
  • Increase fiber intake to prevent constipation

Side Effects and How to Manage Them

Common Side Effects (Most People Experience These)

Gastrointestinal (Most Common):

  • Nausea (most common, usually temporary)
  • Diarrhea or constipation
  • Vomiting
  • Stomach pain
  • Bloating and gas
  • Heartburn/acid reflux

Management strategies:

  • Eat smaller meals
  • Avoid fatty, greasy, or spicy foods
  • Stay hydrated
  • Take anti-nausea medication if prescribed
  • Symptoms usually improve after 4-8 weeks

Other Common:

  • Fatigue
  • Headache
  • Dizziness
  • Injection site reactions

Serious Side Effects (Rare but Important)

Seek medical attention if you experience:

Pancreatitis:

  • Severe abdominal pain that won’t go away
  • Pain radiating to back
  • Nausea and vomiting
  • Stop medication immediately and see doctor

Gallbladder problems:

  • Pain in upper right abdomen
  • Jaundice (yellowing of skin/eyes)
  • Fever
  • Clay-colored stools

Severe allergic reaction:

  • Difficulty breathing
  • Swelling of face, lips, tongue
  • Severe rash

Kidney problems:

  • Dehydration from vomiting/diarrhea can stress kidneys
  • Stay well-hydrated

Hypoglycemia (if also on diabetes medications):

  • Shakiness, sweating, confusion
  • May need to adjust other diabetes medications

Vision changes:

  • Diabetic retinopathy worsening (rare)
  • Report any vision changes

Long-Term Considerations

“Ozempic face”:

  • Rapid weight loss can cause facial volume loss
  • Skin may appear saggy
  • More noticeable in older individuals
  • Not harmful, purely cosmetic

Muscle loss:

  • GLP-1s cause fat AND muscle loss
  • Resistance training recommended
  • Adequate protein intake essential (1g per lb body weight)

Gallstones:

  • Rapid weight loss increases gallstone risk
  • ~3% develop gallstones

Cost and Insurance Coverage

Brand-Name Medication Costs

Without insurance:

  • Wegovy (semaglutide): $1,300-1,500/month
  • Zepbound (tirzepatide): $1,000-1,200/month
  • Mounjaro: $1,000-1,100/month
  • Ozempic: $900-1,000/month

Annual cost: $12,000-18,000

Insurance Coverage

Diabetes indication (Ozempic, Mounjaro):

  • Often covered by insurance
  • Copays: $25-100/month typically

Weight loss indication (Wegovy, Zepbound):

  • Many insurance plans don’t cover weight loss medications
  • Medicare doesn’t cover weight loss drugs
  • Some commercial plans cover with prior authorization

Prior authorization requirements:

  • BMI ≥30 or ≥27 with comorbidities
  • Documented weight loss attempts
  • Medical necessity letter from doctor

Affordable Alternatives: Compounded GLP-1s Through Telehealth

Best for Affordability: Hims offers compounded semaglutide starting at $199/month with medical consultations, weight loss coaching, and discreet delivery. Great for cost-conscious users who want comprehensive support.

Best Overall Program: Ro provides compounded semaglutide ($145-290/month) and tirzepatide with personalized dosing, ongoing physician support, and nutrition guidance. Ideal if you want structured medical supervision.

Best for Budget: Henry Meds specializes in affordable GLP-1 medications with compounded semaglutide at $297/month including consultations and shipping. Perfect if you want the lowest price with quality care.

Compounded semaglutide details:

  • $145-400/month depending on provider and dose
  • Same active ingredient as Wegovy/Ozempic
  • Made by licensed 503B compounding pharmacies
  • Legal due to ongoing Wegovy shortages
  • Quality varies by pharmacy

Compounded tirzepatide details:

  • $350-600/month typical pricing
  • Same active ingredient as Zepbound/Mounjaro
  • More effective than semaglutide (20% vs 15% weight loss)

Compare all weight loss services to find the best option for your budget and needs.

Pros:

  • Much more affordable than brand-name ($1,000-1,500 savings/month)
  • Convenient telehealth delivery
  • No insurance hassles or prior authorization
  • Ongoing medical support included

Cons:

  • Not FDA-approved (though legally compounded)
  • Quality control less rigorous than brand-name
  • Insurance won’t cover compounded versions
  • Long-term supply uncertain if shortages end

Savings Programs

Manufacturer savings cards:

  • Wegovy: $500 off with savings card (if eligible)
  • Mounjaro: $25 copay savings program
  • Check manufacturer websites for current offers

Do You Need to Stay on GLP-1s Forever?

The Reality of Long-Term Use

Most weight regain occurs after stopping:

  • Studies show ~70% of weight comes back within a year of stopping
  • Appetite returns to pre-treatment levels
  • “Food noise” comes back

Why this happens:

  • GLP-1s don’t cure obesity—they manage it
  • Underlying biology unchanged
  • Think of it like blood pressure medication

Current medical thinking:

  • Obesity is a chronic disease requiring ongoing treatment
  • Most people need long-term or lifelong use
  • Similar to diabetes or hypertension medications

Can You Ever Stop?

Some people successfully stop if:

  • They’ve established sustainable healthy habits
  • Significant lifestyle changes made
  • Close monitoring and early intervention if weight returns

Strategies for stopping:

  • Very slow tapering (reduce dose gradually over months)
  • Aggressive diet and exercise program
  • Regular monitoring
  • Restart early if weight trends upward

Realistic expectations:

  • Most people need ongoing treatment
  • Intermittent use may work for some
  • Maintenance dose may be lower than weight loss dose

GLP-1s vs. Other Weight Loss Approaches

GLP-1s vs. Diet and Exercise Alone

Diet/Exercise:

  • Average weight loss: 5-10% with intensive program
  • Difficult to maintain long-term
  • ~80% regain weight within 5 years

GLP-1s + Lifestyle:

  • Average weight loss: 15-20%
  • Better maintenance with continued use
  • Makes diet/exercise much easier (reduced appetite)

Conclusion: GLP-1s are significantly more effective, but lifestyle still matters

GLP-1s vs. Other Weight Loss Medications

Phentermine:

  • Stimulant, suppresses appetite
  • 5-7% weight loss
  • Can’t use long-term (tolerance, side effects)

Contrave (naltrexone/bupropion):

  • 5-9% weight loss
  • Oral medication
  • Less effective than GLP-1s

Qsymia (phentermine/topiramate):

  • 10-12% weight loss
  • Can’t use long-term

GLP-1s are the most effective weight loss medications available.

GLP-1s vs. Bariatric Surgery

Bariatric surgery (gastric bypass, sleeve):

  • Average weight loss: 25-30%
  • One-time procedure
  • Permanent anatomical change
  • Risks of surgery
  • Cost: $20,000-30,000
  • Often covered by insurance

GLP-1s:

  • 15-20% weight loss
  • Ongoing medication
  • Reversible
  • No surgery
  • Cost: $12,000-18,000/year
  • Often not covered for weight loss

Surgery still more effective for severe obesity (BMI >40).

The Bottom Line

GLP-1 medications are highly effective for weight loss:

  • 15-20% body weight loss typical
  • Most effective weight loss medications available
  • FDA-approved and safe when properly used

Best for:

  • BMI ≥30 or BMI ≥27 with health conditions
  • Those who’ve struggled with traditional weight loss
  • People willing to commit to long-term use
  • Those who can afford cost or have insurance coverage

Considerations:

  • Expensive: $1,000-1,500/month brand-name, $200-600/month compounded
  • Side effects common (mostly GI, usually temporary)
  • Likely need ongoing use (not a cure)
  • Require weekly injections
  • Not covered by all insurance

Most important: GLP-1s are tools, not magic. They work best combined with healthy lifestyle changes. They make it dramatically easier to eat less and stick to a healthy diet, but they don’t do the work for you.

Talk to a healthcare provider to determine if GLP-1 medications are right for your weight loss goals.

Weight Loss Guides:

Service Reviews:

Cost Comparisons:


This guide is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any weight loss medication.

Key Takeaways

  • 1

    GLP-1 medications (semaglutide, tirzepatide) produce 15-22% body weight loss by mimicking natural GLP-1 hormone, reducing appetite, slowing digestion, and increasing satiety after meals.

  • 2

    Semaglutide (Wegovy, Ozempic) causes 15-17% weight loss on average; tirzepatide (Mounjaro, Zepbound) is more effective with 20-22% average weight loss in clinical trials.

  • 3

    FDA-approved for adults with BMI 30+ (obesity) or BMI 27+ with weight-related conditions (diabetes, hypertension, sleep apnea)—not for cosmetic weight loss or BMI <27.

  • 4

    Common side effects include nausea (40-50%), vomiting (10-20%), and diarrhea (20-30%)—usually mild, occur during dose escalation, and subside within 4-8 weeks of treatment.

  • 5

    Cost: brand-name $900-1,400/month without insurance; compounded semaglutide $99-350/month; compounded tirzepatide $350-550/month through online weight loss clinics (Hims, Ro, Henry Meds).

  • 6

    GLP-1 medications require indefinite use—clinical trials show 70% of lost weight regained within 12 months of stopping; weight maintenance requires ongoing treatment or lifestyle changes.

Kai Nakano

Health Journalist & Men's Health Specialist

Medical review by Dr. Amara Okonkwo, PharmD, BCPS - Clinical Pharmacotherapy Specialist

View full profile →

Common Questions About GLP-1 Medications for Weight Loss

Common questions about glp-1, semaglutide & tirzepatide answered by our research team.

Q How much weight can you lose on GLP-1 medications?

Average weight loss varies by medication: Semaglutide (Wegovy): 15-17% of body weight over 68 weeks (studies show 33-pound average for 200-pound person). Tirzepatide (Zepbound): 20-22% of body weight (44-pound average for 200-pound person). Liraglutide (Saxenda): 5-10% weight loss. Individual results vary—some lose 25-30%, others 8-12%. Maximum weight loss occurs at 12-18 months. Results depend on adherence, diet, exercise, and starting weight.

Q What's the difference between Ozempic, Wegovy, Mounjaro, and Zepbound?

Ozempic and Wegovy: both contain semaglutide; Ozempic FDA-approved for diabetes (0.5-2mg weekly), Wegovy for weight loss (2.4mg weekly). Mounjaro and Zepbound: both contain tirzepatide; Mounjaro for diabetes (5-15mg weekly), Zepbound for weight loss (5-15mg weekly). They're identical medications marketed differently. Tirzepatide (dual GIP/GLP-1) is more effective than semaglutide (GLP-1 only) but costs more. Many use diabetes versions off-label for weight loss at lower cost.

Q How much do GLP-1 medications cost?

Brand-name prices: Wegovy/Ozempic $900-1,400/month without insurance. Mounjaro/Zepbound $1,000-1,400/month. With insurance: $25-100/month copay if covered. Compounded semaglutide (online clinics): $99-350/month. Compounded tirzepatide: $350-550/month. Providers: Hims ($199-299/month), Ro ($145-290/month), Henry Meds ($297/month), Noom ($149/month). Insurance rarely covers weight loss indication, often covers diabetes use. Compounded versions are legal, safe, and significantly cheaper.

Q Are GLP-1 weight loss medications safe?

Yes, FDA-approved and considered safe for most people when prescribed appropriately. Common side effects (40-50% experience): nausea, vomiting, diarrhea, constipation—usually mild and temporary. Serious risks (rare): pancreatitis (<1%), gallstones (1-2%), kidney problems, thyroid tumors (animal studies, unclear human risk). Not safe for: history of medullary thyroid cancer, multiple endocrine neoplasia type 2, pregnant/breastfeeding. Long-term safety data (5+ years) is still emerging. Benefits typically outweigh risks for obesity treatment.

Q Do you have to inject GLP-1 medications?

Currently, yes—all FDA-approved GLP-1 medications for weight loss are injectable (semaglutide, tirzepatide, liraglutide). Injections are subcutaneous (under skin, not into muscle), weekly for semaglutide/tirzepatide, daily for liraglutide. Injections use small needles (similar to insulin) in abdomen, thigh, or upper arm. Oral semaglutide (Rybelsus) exists for diabetes but not approved/effective for weight loss. Most users report injections are easy and painless after first few times. Pill versions are in development but not yet available.

Q What happens when you stop taking GLP-1 medications?

Weight regain is common and expected. Clinical studies show: 70% of lost weight returns within 12 months of stopping. Appetite returns to pre-medication levels within 2-4 weeks. Some regain all weight lost, others maintain partial loss with lifestyle changes. To maintain weight loss after stopping: intensive lifestyle modification (diet, exercise), behavioral therapy, or transition to maintenance medication. Most doctors recommend indefinite use for obesity treatment, similar to managing chronic conditions like diabetes or hypertension.

Q Can anyone get a prescription for GLP-1 weight loss medication?

No, FDA approval requires: BMI 30+ (obesity), OR BMI 27+ with at least one weight-related condition (type 2 diabetes, hypertension, high cholesterol, sleep apnea, PCOS). Not approved for: cosmetic weight loss, BMI <27 without medical conditions, people at healthy weight wanting to lose 5-10 pounds. Contraindications: pregnancy, history of medullary thyroid cancer, multiple endocrine neoplasia type 2. Legitimate telehealth providers verify BMI and medical eligibility before prescribing.

Q How long does it take for GLP-1 medications to work for weight loss?

Timeline for results: 2-4 weeks: reduced appetite, smaller portions, early weight loss (2-5 pounds). 4-8 weeks: noticeable weight loss (5-10 pounds), nausea typically subsides. 3-6 months: significant weight loss (10-15% of body weight). 12-18 months: peak weight loss (15-22% depending on medication). Weight loss continues for 12-18 months, then plateaus. Slower results at lower doses—dose escalation occurs over 4-5 months to minimize side effects.

Q What are the side effects of semaglutide and tirzepatide?

Common side effects (frequency): Nausea (40-50%), diarrhea (20-30%), vomiting (10-20%), constipation (15-20%), abdominal pain (10%), fatigue (10%), headache (10%). Most side effects: occur during dose escalation, peak at weeks 2-4, subside by week 8-12, are mild to moderate. Strategies to reduce: slow dose increases, eat smaller meals, avoid fatty foods, stay hydrated. Serious but rare: pancreatitis (<1%), gallstones (1-2%), severe dehydration from vomiting. About 5-10% discontinue due to intolerable side effects.

Q Is compounded semaglutide as effective as Wegovy?

Yes, compounded semaglutide contains the same active ingredient (semaglutide) at identical doses and is equally effective for weight loss. Differences: Compounded versions are made by FDA-registered 503B compounding pharmacies (legal and regulated), cost $99-350/month vs $900-1,400 for brand-name, may have slightly different inactive ingredients. The FDA allows compounding due to Wegovy shortages. Effectiveness is the same—15-17% average weight loss. However, compounded versions lack the same FDA approval process as brand-name medications.

Have more questions? Our research is continuously updated. If you don't see your question answered here, check our complete guides or contact our team.

References

  1. 1. Once-Weekly Semaglutide in Adults with Overweight or Obesity - New England Journal of Medicine
  2. 2. Tirzepatide Once Weekly for the Treatment of Obesity - New England Journal of Medicine
Personalized Recommendations

Find Your Best Match

Answer 2 quick questions to get personalized service recommendations

1
2
3

What are you looking for?

Choose the option that best describes your needs